Elon's Next Millionaire-Making Project?

This could create more wealth than all of his previous ventures... combined.

Ozempic, Wegovy and other drugs are among 15 selected for Medicare's price negotiations

AMANDA SEITZ
January 17, 2025

WASHINGTON (AP) -- Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said Friday.

The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration and almost assures billions of dollars in savings for taxpayers.

Besides Ozempic and Wegovy, some of the other medications include Trelegy Ellipta, which treats asthma; Otezla, a psoriatic arthritis drug; and several that treat different forms of cancer.

The list is a first step in negotiations and, given the timing, the details and final pricing will be left to President-elect Donald Trump's administration.

"For some people this is a big deal," U.S. Health and Human Services Secretary Xavier Becerra said in a call with reporters on Thursday. "Some folks have to skip a dose in their prescription so they can make a prescription last longer."

That brings the total to 25 drugs that will have lower price tags. Those 25 drugs account for a third of Medicare spending on prescriptions, Becerra said.

The savings will stem from a new law that allows Medicare to haggle over the price it pays on the most popular and expensive prescription drug scripts filled by older Americans. For years, Medicare had been legally prohibited from such dealmaking. The law, passed by Democrats and signed into law by President Joe Biden, was opposed by Republicans at the time, but it's unclear if they have an interest in trying to repeal or weaken the law now.

Although drug companies have sued over the negotiations, they engaged in the talks with the federal government. Pharmaceutical executives last year had said during earnings calls that they don't expect the new Medicare drug prices to impact their bottom line.

Late last year, the Centers for Medicare and Medicaid Services announced it had reached pricing deals with companies for 10 drugs in the inaugural round of negotiations. Under the new deals, list prices were reduced by hundreds -- in some cases, thousands -- of dollars for 30-day supplies of popular drugs used by millions of people on Medicare. They included popular blood thinners Xarelto and Eliquis and diabetes drugs Jardiance and Januvia.

The savings from the new list prices for those drugs were expected to generate about $6 billion for taxpayers and $1.5 billion for Medicare enrollees.

Negotiated prices for the drugs don't kick in until 2026. But some Medicare enrollees should see relief from drug prices in a new rule this year that caps annual out-of-pocket costs on prescription drugs to $2,000.

Under the law, more drugs will be added to the negotiation process in coming years.

The Centers for Medicare and Medicaid Services says the 15 drugs are Ozempic, Rybelsus and Wegovy; Trelegy Ellipta; Xtandi; Pomalyst; Ibrance; Ofev; Linzess; Calquence; Austedo and Austedo XR; Breo Ellipta; Tradjenta; Xifaxan; Vraylar; Janumet and Janumet XR; and Otezla.

Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey.

Continue Reading...

Popular

What to know about Trump's buyout proposal for federal employees

President Donald Trump's administration is offering to federal employees to quickly reduce the government workforce. They don't have a long time to decide: The deadline is Feb. 6.

Nvidia faces a reckoning as an upstart rival raises questions about Wall Street's darling

NEW YORK (AP) — The superstar run for Nvidia’s stock the last few years has been astonishing. So was its tumble Monday, which caused $595 billion in wealth to vanish. That’s about as much as PepsiCo, McDonalds, Starbucks and Target are worth, combined.

Struggling to Get By? This Could Be a Godsend - Ad

If you knew with 90% certainty, Amazon was about to tack on 22.5% to its share price... AND you also knew exactly when that climb would start and end... how much money do you think you'd be able to rake in? $1,000... $5,000... $25,000... Maybe even more? If you'll give me 5 minutes... I'd like to help you answer that question.

Trump's Commerce Secretary nominee, Howard Lutnick, vows to sell his business interests in 90 days

WASHINGTON (AP) — Billionaire financier Howard Lutnick, President Donald Trump's choice to lead the Commerce Department, said Wednesday that he would sell all of his business holdings within 90 days.

Undervalued Stock Riding the $22B Electric Boating Wave - Ad

In a booming $22 billion market, one company is redefining electric boating with record-breaking technology and strategic partnerships. With production scaling fast and an innovative powertrain already in demand.

Edmunds' hybrid SUV test: 2025 Hyundai Tucson Hybrid vs 2025 Toyota RAV4 Hybrid

Hybrids are hot right now, and you have lots of choices if you’re considering a hybrid SUV. For years, the Toyota RAV4 Hybrid has been the go-to model for hybrid SUV shoppers.

Cathie Wood Dumps Tesla Stock Ahead Of Q4 Earnings, Ark Invest Loads Up On Amazon

On Tuesday, Jan. 28, 2025 Cathie Wood-led Ark Invest sold shares of Tesla ahead of its fourth-quarter earnings. Wood purchased Amazon shares on the same day.

Is This Defi Coin Your Next "10-Bagger" Investment? - Ad

Our #1 pick in decentralized finance is largely overlooked by mainstream investors (for now). This governance token could skyrocket as DeFi adoption surges with the smart money and institutions.

Apple Surprises Users With Starlink Beta, Teams Up With Elon Musk's SpaceX And T-Mobile To Bring Satellite Texting For iPhone Users In iOS 18.3

Apple has partnered with SpaceX and T-Mobile to bring Starlink satellite texting to iPhones, with a limited beta test rolling out via iOS 18.3, marking a major step toward expanding connectivity in remote areas.

Magnificent 7 Earnings Ahead: 3 ETFs To Ride The Wave

Earnings season in full swing, attention on tech giants known as Magnificent 7: 3 ETFs to consider.

Say Goodbye to Trading Losses - Ad

Tired of losing? Pivozon MM4 EA is the solution! It's optimized for XAUUSD H1 timeframe, on high level ticks data from DukasCopy since 2016 till present. The main core is fixed SL/TP, low DrawDown under 37% and impressive WinRate above 60%. Pivozon avoids dangerous methods like Hedge, Grid, Scalping or Arbitrage. Enjoy over 100% yearly returns, and advanced equity and spread protections.

Senate confirms Zeldin to lead Environmental Protection Agency as Trump vows to cut climate rules

WASHINGTON (AP) — The Republican-controlled Senate on Wednesday confirmed Lee Zeldin to lead the Environmental Protection Agency, a key role to help President Donald Trump fulfill his pledge to roll back major environmental regulations, including those aimed at slowing climate change and encouraging use of electric vehicles.

Shipments of uranium ore can resume under agreement reached with the Navajo Nation

Shipments of uranium ore from just south of the Grand Canyon are expected to resume in February after the Navajo Nation reached a settlement with the mining company, clearing the way for trucks to transport the ore across the largest Native American reservation in the U.S.

Elon Musk's Critical Metals Warning: What Investors Need to Know - Ad

Elon Musk has repeatedly warned about the looming critical metals crisis, calling materials like nickel, copper, and PGMs essential to Tesla's future. One Canadian discovery in Quebec is drawing comparisons to Russia's Norilsk Mine and has the potential to reshape global supply chains. With heavyweight backers and a fully funded exploration plan, this opportunity demands attention.

Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth

Wall Street analysts upgraded Stryker Corp (NYSE: SYK) after its Q4 report beat expectations, with strong sales and earnings growth projected for 2025.

Critical Metals: The Linchpin of the Energy Transition - Ad

As EVs and AI take center stage, critical metals like copper, nickel, and PGMs are becoming the linchpin of clean energy and technological advances. One Canadian company's high-grade polymetallic discovery in Quebec is drawing comparisons to Russia's Norilsk Mine--one of the richest deposits globally. Backed by industry titans, this story is just beginning.

Bill Ackman Questions Whether DeepSeek AI's Hedge Fund Affiliate Profited From Nvidia's Sell-Off: 'A Fortune Could Have Been Made'

Billionaire investor Bill Ackman questioned whether DeepSeek's hedge fund affiliate potentially profited from Monday's tech stock rout, which saw Nvidia Corp. shares plunge 17% following the Chinese artificial intelligence startup's emergence as a potential disruptor.

3 coup-hit West African nations formally leave ECOWAS in an unprecedented disintegration

ABUJA, Nigeria (AP) — The of Niger, Mali and Burkina Faso have formally withdrawn from the regional bloc known as ECOWAS, the body said Wednesday, the culmination of a yearlong process during which the group tried to avert its unprecedented disintegration.

Musk and Trump Bullish on New Tech Beyond AI - Ad

Elon Musk is heavily invested in a cutting-edge new technology. In fact, Musk has turned the new president on to this breakthrough. And President Trump could make an announcement any day that could spike the price of stocks in this sector.

Coinbase Taps Trump's Campaign Manager, Chris LaCivita To Tackle Crypto Policy In Washington

Coinbase adds former Trump campaign manager and Senator Sinema to advisory team, highlighting crypto's efforts for influence and clear regulations.

F5 Sees Big Wins in Multi-Cloud, AI Security, and IT Refresh, Analysts Forecast More Upside

F5 Inc (NASDAQ: FFIV) reported strong Q1 results, beating revenue and EPS estimates. The stock gained as analysts raised price targets and expectations for further growth from IT budgets, data center refresh, and AI demand.

Looking for a Low-Risk Trade? You Need to See This - Ad

He quit his job as a high-powered attorney at the age of 37 and became a million-dollar trader. Now -- for the first time -- he's sharing his biggest secret... one he calls "profit windows." Discover how this simple 'trick' pinpoints trades for you that deliver gains of 116%... 137%... and even 227%... In weeks (NOT years).

Stock market today: Asia shares mostly rise while some regional markets stay closed for holidays

TOKYO (AP) — Asian shares mostly rose Thursday after the U.S. Federal Reserve opted for the first time since it began trying to help through easier rates in September.

AI ETFs In Focus As Alibaba Challenges DeepSeek With New Model

AI arms race fueled by DeepSeek and Alibaba's AI models. Investors can profit from trend with AI-focused ETFs, including AIQ, ARKQ, QQQ.

Love or Hate Him -- You Have To See What Elon Could Do Next - Ad

It's not electric vehicles, green energy or space travel that Elon Musk will be remembered for.

Shiba Inu's Shytoshi Kusama Teases 'Extremely Powerful Partnership' -- Coin Themed On Him Rallies 25%

Shiba Inu (CRYPTO: SHIB) lead ambassador Shytoshi Kusama hinted at a major partnership announcement for the blockchain ecosystem on Tuesday, stirring up excitement among enthusiasts.

Dan Ives Expects Meta And Microsoft To Stand Firm On $60 - $80 Billion AI Spending Plans Amid DeepSeek's Disruptive AI Model

Wedbush Securities analyst Dan Ives expects Meta Platforms Inc. and Microsoft Corp. to stand firm on their ambitious artificial intelligence spending plans during their upcoming earnings calls, despite recent market jitters over Chinese AI startup DeepSeek's emergence.

The Closest Thing to 'Push Button' Investing - Ad

You buy when these 'windows' open -- and sell when they close... Yes, it's that easy. It doesn't matter if you're just starting out, or if you've been investing for decades... This brain-dead simple trading strategy is designed to deliver triple-digit gains - WITHOUT tying your money up for years on end.

Ozempic Receives FDA Approval To Treat Kidney Disease

The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease in patients who also have type 2 diabetes. 

Lyft Faces Growing Competition, Bank of America Analyst Warns

Bank of America analyst Micheal McGovern reiterated a Buy rating on Lyft and lowered the price target from $21 to $19.

"Trump Coins:" the Next Big Thing - Ad

Have you heard of "Trump Coins?" Even though these coins are associated with or endorsed by President Trump... Tech legend Jeff Brown believes his policies will help send these coins higher than anyone can imagine in 2025.

Elon Musk's Tesla Records $600 Million In Paper Gains On Bitcoin In Q4 Thanks To New Accounting Rule

Electric vehicle behemoth Tesla Inc. (NASDAQ:TSLA) reported an unrealized gain of $600 million on its cryptocurrency holdings in the fourth quarter.

Trump Could Make Surprising Tech Announcement Any Day - Ad

Elon Musk is heavily invested in a cutting-edge new technology. In fact, Musk has turned the new president on to this breakthrough. And President Trump could make an announcement any day that could spike the price of stocks in this sector.

Robert Kiyosaki Predicts Yet Another Stock Market Crash, Pitches Bitcoin Investments -- Here's What The 'Rich Dad Poor Dad' Author Said

Renowned investor and author Robert Kiyosaki on Monday predicted a major stock market crash in February and advised investors to focus on Bitcoin (CRYPTO: BTC), gold, and silver.

Bank of America's Sensitive Customer Data Compromised in Third-Party Hack - Is Your Account Safe?

Bank of America (NYSE: BAC) has confirmed a data breach involving a third-party software provider that led to the exposure of sensitive customer data.

The Elon Shock - Ad

All of Elon Musk's strange behavior in recent times is starting to make sense. His feuds with other leading technologists like Sam Altman and Bill Gates has all been building up to what he's been planning in Washington. It's a fascinating new financial story that some say could change life in America forever.

DeepSeek Suffers 'Degraded Performance,' Says Hit By 'Large-Scale Malicious Attacks' After Rapidly Emerging As App Store Chart Topper

Chinese AI startup DeepSeek faced significant cyberattacks amid its rapid rise, including topping the U.S. App Store and challenging AI giants with its cost-effective R1 language model.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright systemtrading.ca
Privacy Policy | Terms of Service